Director/PDMR Share Dealings
September 30, 2013 - Shire plc (LSE: SHP, NASDAQ: SHPG) announces that Graham
Hetherington was granted on September 27, 2013, under the Shire Sharesave
Scheme, an option over 467 ordinary shares at an exercise price of £19.24 per
This notification relates to disclosures made in accordance with 3.1.4(R)(1)(a)
of the Disclosure and Transparency Rules.
Deputy Company Secretary
For further information please contact:
Eric Rojas email@example.com +1 781 482 0999
Sarah Elton-Farr firstname.lastname@example.org +44 1256 894157
Notes to editors
Shire enables people with life-altering conditions to lead better lives.
Our strategy is to focus on developing and marketing innovative specialty
medicines to meet significant unmet patient needs.
We provide treatments in Neuroscience, Rare Diseases, Gastrointestinal,
Internal Medicine and Regenerative Medicine and we are developing treatments
for symptomatic conditions treated by specialist physicians in other targeted
Registered in Jersey, No. 99854, 22 Grenville Street, St Helier, Jersey JE4 8PX
-0- Sep/30/2013 15:15 GMT
Press spacebar to pause and continue. Press esc to stop.